Brianna Gerber Net Worth

The estimated Net Worth of Brianna Gerber is at least 91.1 千$ dollars as of 1 December 2023. Brianna Gerber owns over 5,000 units of Chromadex Corp stock worth over 91,088$ and over the last 2 years he sold CDXC stock worth over 0$. In addition, he makes 0$ as Vice President of FP&A and Investor Relations at Chromadex Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Brianna Gerber CDXC stock SEC Form 4 insiders trading

Brianna has made over 2 trades of the Chromadex Corp stock since 2023, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of CDXC stock worth 7,050$ on 1 December 2023.

The largest trade he's ever made was exercising 22,436 units of Chromadex Corp stock on 12 August 2023 worth over 74,488$. On average, Brianna trades about 5,487 units every 22 days since 2022. As of 1 December 2023 he still owns at least 27,436 units of Chromadex Corp stock.

You can see the complete history of Brianna Gerber stock trades at the bottom of the page.

Brianna Gerber biography

Brianna Gerber is the Vice President of FP&A and Investor Relations at Chromadex Corp.

What's Brianna Gerber's mailing address?

Brianna's mailing address filed with the SEC is 10900 WILSHIRE BLVD. SUITE 600, , LOS ANGELES, CA, 90024.

Insiders trading at Chromadex Corp

Over the last 16 years, insiders at Chromadex Corp have traded over 0$ worth of Chromadex Corp stock and bought 25,157,946 units worth 26,482,051$ . The most active insiders traders include Ka Shing Prime Tech Global ...、Hoi Shuen Solina Holly Pion...、Steven D Rubin. On average, Chromadex Corp executives and independent directors trade stock every 120 days with the average trade being worth of 2,496,872$. The most recent stock trade was executed by Kristin Patrick on 23 August 2024, trading 23,000 units of CDXC stock currently worth 38,410$.

What does Chromadex Corp do?

chromadex corp. is an integrated, global nutraceutical company devoted to improving the way people age. chromadex scientists partner with leading universities and research institutions worldwide to uncover the full potential of nad and identify and develop novel, science-based ingredients including pteropure® pterostilbene; purenergy®, a caffeine-pteropure® co-crystal; anthorigin™, anthocyanins and niagen® nicotinamide riboside - sold directly to consumers as the supplement, tru niagen®. tru niagen® is helping the world age better®. for more, visit www.chromadex.com like us on facebook here: https://www.facebook.com/chromadex or follow us on twitter @chromadex chromadex® is publicly-traded company (nasdaq:cdxc).

Complete history of Brianna Gerber stock trades at Chromadex Corp

Chromadex Corp executives and stock owners

Chromadex Corp executives and other stock owners filed with the SEC include:

• Robert Fried,
  Chief Executive Officer, Director
• Robert N. Fried,
  CEO & Director
• Frank Jaksch,
  Executive Chairman of the Board
• Mark Friedman,
  General Counsel, Corporate Secretary
• Kevin Farr,
  Chief Financial Officer
• Frank Louis Jaksch Jr.,
  Co-Founder & Exec. Chairman
• Kevin M. Farr CPA,
  Chief Financial Officer
• Mark J. Friedman,
  Chief Legal Officer
• Kurt Gustafson,
  Lead Independent Director
• Stephen Block,
  Independent Director
• Jeffrey Baxter,
  Independent Director
• Steven Rubin,
  Independent Director
• Tony Lau,
  Independent Director
• Wendy Yu,
  Independent Director
• Brianna Gerber,
  Vice President of FP&A and Investor Relations
• Megan Jordan,
  Chief Communications Officer and Senior Vice President of Global Marketing
• Fadi Karam,
  Chief Marketing Officer
• Alex Worsham,
  VP of Global Marketing & Communications
• Will T. Black,
  Consultant
• Frank M. Fazio,
  Sr. VP of Global Bus. Devel. & Sales
• Lisa Hatton Harrington,
  Gen. Counsel & Corp. Sec.
• Dr. Andrew Shao Ph.D.,
  Sr. VP of Global Regulatory & Scientific Affairs
• Ben Shichman,
  Chief Technology Officer
• Kristin Patrick,
  Director
• Ann Cohen,
  Director
• Matthew A Roberts,
  CHIEF SCIENTIFIC OFFICER
• Lisa Bratkovich,
  CHIEF MARKETING OFFICER
• Troy Allen Rhonemus,
  CHIEF OPERATING OFFICER
• Margie Chassman,
  10% owner
• Stephen R. Allen,
  
• Step Holdings Ltd Chau Hoi ...,
  
• River Ventures Ltd Prime Te...,
  
• Thomas C Varvaro,
  CFO, TREASURER AND SECRETARY
• Lisa Hatton Harrington,
  GENERAL COUNSEL
• Jeff Baxter,
  Director
• River Ventures Ltd Prime Te...,
  
• Wang Yu Gary Ng,
  Director
• Caroline S Levy,
  Director
• Hamed Shahbazi,
  Director
• Hoi Shuen Solina Holly Pion...,
  
• Ka Shing Prime Tech Global ...,